Ractigen’s RAG-01 shows potential in treating non-muscle invasive bladder cancer
The company’s Phase I trial found that patients remained disease free after three months utilising the lowest doses of RAG-01 ...
PipelineReview.com21 小时
SineuGene Therapeutics Announces FDA IND Clearance for SNUG01, a First-in-Class TRIM72 ...
BEIJING, China I March 24, 2025 I SineuGene Therapeutics Co., Ltd. ("SineuGene"), a clinical-stage biotech company pioneering innovative therapies for ...
Lourdes Leon’s music era continues—Madonna says she’s “so proud"
Lourdes Leon is getting back into the swing of things in the music industry, and her biggest fan might be her famous mom. The ...
First Patient Dosed in Immutep’s TACTI-004 Phase III Trial in First Line Non-Small Cell ...
First patient safely dosed at Calvary Mater Newcastle Hospital in Australia, marking a significant milestone for ImmutepGlobal Phase III with ...
FNArena17 小时
Ractigen’s RAG-01 Shows Promising Early Complete Responses in Phase I NMIBC Trial, Data ...
NANTONG, China and MELBOURNE, Australia, March 24, 2025 /PRNewswire/ -- Ractigen Therapeutics, a clinical-stage biopharmaceutical company pioneering small ...
eLife21 小时
Loss of CTRP10 results in female obesity with preserved metabolic health
Mice lacking the secreted hormone, CTRP10, represent a unique female model of obesity with preserved metabolic health, highlighting sex-specific mechanisms that uncouple obesity from metabolic ...
Will Smith channels his post-slap introspection into music on ‘Based on a True Story'
Will Smith could have let his infamous Oscar slap be his cinematic fade out with a career bruised, a marriage dissected and a ...